ESC 365 - Q&A - Challenging paradigms and changing the course of chronic kidney disease the era of SGLT2i.

Open Access

Q&A - Challenging paradigms and changing the course of chronic kidney disease the era of SGLT2i.

Session: Challenging paradigms and changing the course of chronic kidney disease (CKD) The era of SGLT2i

Topic: Renal Failure and Cardiovascular Disease

Speaker: Professor H. Heerspink (Groningen, NL) Associate Professor J. Tan (Singapore, SG)

Sponsored by AstraZeneca

Event: ESC Asia with APSC & AFC 2020

Congress Presentation

Add to my library

About the speakers

Professor Hiddo Heerspink

University Medical Centre Groningen, Groningen (Netherlands (The))

5 presentations

0 follower

Associate Professor Jack Wei Chieh Tan

National Heart Centre Singapore, Singapore (Singapore)

14 presentations

2 followers

1 more presentation in this session

Challenging paradigms and changing the course of chronic kidney disease the era of SGLT2i.

Speaker: Professor H. Heerspink (Groningen, NL)

Access the full session

Challenging paradigms and changing the course of chronic kidney disease (CKD) The era of SGLT2i

Speakers: Professor H. Heerspink, Associate Professor J. Tan, Professor H. Heerspink

About the event

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources